Cite
Prognostic Value of Pretherapeutic Primary Tumor MTV from [18F]FDG PET in Radically Treated Cervical Cancer Patients
MLA
Paulina Cegla, et al. “Prognostic Value of Pretherapeutic Primary Tumor MTV from [18F]FDG PET in Radically Treated Cervical Cancer Patients.” Metabolites, vol. 11, no. 12, Nov. 2021, p. 809. EBSCOhost, https://doi.org/10.3390/metabo11120809.
APA
Paulina Cegla, Frank Hofheinz, Witold Cholewiński, Rafał Czepczyński, Anna Kubiak, Jörg van den Hoff, Agnieszka Boś-Liedke, Andrzej Roszak, & Ewa Burchardt. (2021). Prognostic Value of Pretherapeutic Primary Tumor MTV from [18F]FDG PET in Radically Treated Cervical Cancer Patients. Metabolites, 11(12), 809. https://doi.org/10.3390/metabo11120809
Chicago
Paulina Cegla, Frank Hofheinz, Witold Cholewiński, Rafał Czepczyński, Anna Kubiak, Jörg van den Hoff, Agnieszka Boś-Liedke, Andrzej Roszak, and Ewa Burchardt. 2021. “Prognostic Value of Pretherapeutic Primary Tumor MTV from [18F]FDG PET in Radically Treated Cervical Cancer Patients.” Metabolites 11 (12): 809. doi:10.3390/metabo11120809.